London (United Kingdom), April 24, 2017 – SNOMED International today announced its newly appointed Management Board. The Management Board renewal process initiated in February 2017 to support SNOMED International’s effectiveness, sustainability and organizational growth as well as improved alignment in terms of culture and narrative regarding authority and ownership. Further, following an industry best practice approach, SNOMED International has reduced its number of members on the Management Board from 10 to 7 members.
Through the renewal process, the Management Board Nominating Committee considered a total of 66 applications for the vacant positions. It was an extremely difficult process to select candidates, as there were many excellent individuals that had expressed their interest to support SNOMED International in a Directorial capacity.
The authority of new Management Board members comes into force effective 12:00 noon BST, 24th April 2017. Newly appointed Management Board members include:
Lady Barbara Judge CBE, Chair
Lady Barbara Judge CBE is the National Chairman of the UK Institute of Directors, as well as Chairman Emeritus of the UK Atomic Energy Authority, having been its Chairman from 2004-2010. She is also currently Chairman of the Energy Institute of University College London and Deputy Chairman of the Tepco Nuclear Reform Committee. In addition, she is a UK Business Ambassador. She is also a member of the UAE Advisory Board for the Development of Peaceful Nuclear Energy and Chairman of the Advisory Board for the Association of Consultancy and Engineering (ACE). In addition she is a Visiting Fellow at Oxford University.
In June 2016 she completed two terms as Chairman of the UK Pension Protection Fund. Earlier in her career she was appointed as the youngest ever Commissioner of the US Securities and Exchange Commission. Thereafter she was appointed as the first woman Executive Director of Samuel Montagu and News International.
In 2010 Lady Judge was awarded Commander of the British Empire in the Queen’s Birthday Honours List and in 2015 she received a Sunday Times Non-Executive Director Award for her chairmanship of the Pension Protection Fund.
Lady Judge will serve as the Chair of the SNOMED International Management Board.
Cheemin Bo-Linn
Dr. Bo-Linn is CEO and President of Peritus Partners,Inc. and sits on the Board of Directors for Evena Medical and other public company boards. Dr. Bo-Linn previously held the role of Vice-President of IBM Corp. and was recognized for innovative leadership as the 2015 inductee into the "Hall of Fame for Women in Science and Technology". In 2016, Dr. Bo-Linn was honored as "Top CEOs Leading STEM" (Science, Tech, Engineering, and Mathematics).
Douglas B. Fridsma, MD, PhD, FACP, FACMI*
Dr. Fridsma is the President and Chief Executive Officer of the American Medical Informatics Association (AMIA). Prior to joining AMIA, Dr. Fridsma was the Chief Science Officer for the Office of the National Coordinator for Health Information Technology, U.S. Department of Health and Human Services, and has held academic appointments at the University of Pittsburgh, Arizona State University, University of Arizona, and Mayo Clinic.
Gong Mengchun
Dr. Gong is the Executive Director, National Rare Diseases Registry System of China. Dr. Gong was previously a physician at the Department of Internal Medicine, Peking Union Medical College Hospital, as well as serving as the Medical Informatics Consultant for Fudan University, Children’s Hospital.
Jeremy Thorp*
Jeremy Thorp is the Business Architecture Director, Health & Social Care Information Centre, NHS. He has led UK input to European projects epSOS, EXPAND and the Joint Action to support the eHealth Network; he has also been a member of the HL7 International Board and UK Head of Delegation to CEN and ISO health informatics committees.
Joanne Burns
Joanne Burns is the Chief Strategy Officer for the Cerner Corporation. Ms. Burns has held leadership roles with Cerner, the Tiger Institute for Health Innovation and Stanford University Medical Center. Ms. Burns has extensive experience setting up and leading governance boards and received Program Certification in “Women on Boards” from the Harvard T.H Chan School of Public Health in 2016.
Matic Meglic
Dr. Meglic is the Digital Health Director EMEA at Medtronic. Dr. Meglic has been a contributor to EU public health informatics as CIO, Slovene National Institute of Public Health and coordinator of the key EU ePublicHealth policy project PARENT. Dr. Meglic has also served as Co-chair of epSOS Steering Board and actively contributed to a number of other EU semantic interoperability initiatives.
*Douglas Fridsma and Jeremy Thorp fulfill the 2 positions secured for continued representation from the previous SNOMED International Management Board.
The Management Board has legal and oversight responsibility for the management and direction of SNOMED International. The terms of the appointments are staggered with the longest term being three years and the shortest being one year. Management Board appointments are non-executive Director positions which carry legal responsibility for the governance of the organization.
For additional information on the newly elected Management Board, including profiles and terms of service, please visit www.snomed.org.
SNOMED International wishes to extend its sincerest gratitude to previous Management Board members for their excellent dedication and stewardship, both as it has related to the organization’s strategic direction as well as guidance and participation throughout the management renewal process.
SNOMED International
Owned and governed by its international Member countries, SNOMED International is a not-for-profit organization that produces and enhances the vocabulary that enables the clear exchange of health information for all. The organization provides full support to its global Members and licensees, ensuring that those combined resources achieve significant shared benefits that resonate around the world.
SNOMED International owns, administers and develops SNOMED CT, a product that enables the establishment of semantically accurate clinical terminologies for consistent use across all health systems, services and products in the world. As of January 1, 2017, SNOMED International became the trading name of IHTSDO.
Media Inquiries:
Kelly Kuru, Executive Lead, Communications
SNOMED International
Telephone: +1-416-566-8725 (Canada)
Email: kku@snomed.org
www.snomed.org
Clinical engagement at SNOMED International is changing! SNOMED International continues to evolve its approach to clinical engagement with the newly created Clinical Reference Groups. To enable continuous development of SNOMED CT, it is critical that its clinical content is relevant and up to date. To do this, we rely on input from both clinicians and clinical groups internationally.
Why should clinicians continue their contributions as SIGs transition to Clinical Reference Groups? Engaging via Clinical Reference Groups provides clinicians with a mechanism to ensure that the content required by clinicians is included in SNOMED CT quickly and accurately.
The SIGs will formally retire on April 13, 2017 with the launch of the Clinical Reference Groups. Once the Clinical Reference Groups pages are established on Confluence, the existing membership for each SIG will be migrated across. Please visit the Clinical Reference Groups Confluence page to learn more, or contact the Clinical Engagement Team with your questions concerning approach and participation.
A key emerging theme globally is the requirement to link clinical medications data and the data required for pharmacovigilance, regulation and supply chain.
Following requests from SNOMED International Members and other stakeholders, SNOMED CT® has drafted a position statement describing the relationship between the proposed SNOMED CT Pharmaceutical/biologic product concept model and other international standards. Please click here to download the full document.
This position statement is geared towards the following bodies for information and feedback as applicable:
- Policy makers, or equivalent agencies
- SNOMED International stakeholder groups
- Standards Development Organizations (SDOs)
- SNOMED CT® implementers and software vendors
- Pharmaceutical regulators and the pharmaceutical industry
SNOMED International welcomes all opportunities to discuss partnerships in order to advance our drug content and quality for our members and stakeholders.
For additional information, please contact info@snomed.org.
SNOMED International April 2017 Business Meeting
Sunday 23rd to Wednesday 26th April 2017
The Corporate Services Team would like to remind everyone that registration for the forthcoming SNOMED International April 2017 Business Meeting is now open.
If you intend to attend and have yet to register please click the link below to complete the process asap:
http://www.cvent.com/d/95qkbm/4W
Please note: This is only for those who are attending in person - registration for those dialling-in to meetings is not required.
The full confirmed schedule for the event is available to download here:
http://www.snomed.org/participate/attend-our-events/snomed-international-business-meetings/
The link above also contains useful information about booking your hotel accommodation, as well as some travel advice.
As previously noted, please be aware that due to the London Marathon we are in the unusual situation of having our Sunday sessions in a different area of London to the weekday meetings. The meetings on Sunday 23rd are being held at the Novotel Paddington. This hotel is right near Paddington station, so is a very easy transfer for those arriving via Heathrow. For the weekday meetings (24th-26th) we will return to the Amba Hotel in Charing Cross.
Please contact us by email at events@snomed.org if you have any questions – we hope to see you in London!
SNOMED International seeks a proposal from a suitable organization or a qualified individual to provide content services of SNOMED CT National Drug Extension.The request for a proposal has been made by the Executive Lead, Content and Mapping and the Head of Terminology of SNOMED International.
Please click here for full details, including instructions on how to submit.
SNOMED International will accept responses until 17:00 UTC May 18, 2017.